In today’s recent session, 0.49 million shares of the Aptose Biosciences Inc (NASDAQ:APTO) have been traded, and its beta is 1.20. Most recently the company’s share price was $0.33, and it changed around -$0.03 or -8.41% from the last close, which brings the market valuation of the company to $8.94M. APTO at last check was trading at a discount to its 52-week high of $2.91, offering almost -781.82% off that amount. We note from Aptose Biosciences Inc’s average daily trading volume that its 10-day average is 0.14 million shares, with the 3-month average coming to 539.43K.
Aptose Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended APTO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Aptose Biosciences Inc is expected to report earnings per share of -0.69 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptose Biosciences Inc (NASDAQ:APTO) trade information
Instantly APTO has been showing red trend so far today with a performance of -8.41% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3899 on recent trading dayincreased the stock’s daily price by 15.36%. The company’s shares are currently down -87.05% year-to-date, but still down -13.51% over the last five days. On the other hand, Aptose Biosciences Inc (NASDAQ:APTO) is -17.75% down in the 30-day period. We can see from the shorts that 0.12 million shares have been sold at a short interest cover period of 1.82 day(s).
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 15.87% of Aptose Biosciences Inc shares, and 16.68% of them are in the hands of institutional investors. The stock currently has a share float of 19.83%. Aptose Biosciences Inc stock is held by 31.0 institutions, with DOHENY ASSET MANAGEMENT /CA being the largest institutional investor. By 2024-06-30, it held 0.3849% of the shares, which is about 50550.0 shares worth $0.32 million.
CALDWELL SUTTER CAPITAL, INC., with 0.0007% or 92.0 shares worth $70.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity NASDAQ Composite Index Fund and DFA Investment Dimensions-Canadian Small Company Series were the top two Mutual Funds as of Sep 30, 2024. The former held 2.16 shares worth $711.0, making up 0.01% of all outstanding shares. On the other hand, DFA Investment Dimensions-Canadian Small Company Series held roughly 767.0 shares worth around $252.0, which represents about 0.00% of the total shares outstanding.
